Aspen Aerogels (NYSE:ASPN) Stock Price Passes Below 50-Day Moving Average – What’s Next?

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $4.34 and traded as low as $2.88. Aspen Aerogels shares last traded at $2.9640, with a volume of 2,231,547 shares trading hands.

Wall Street Analysts Forecast Growth

ASPN has been the subject of several research reports. Barclays dropped their target price on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research report on Friday, November 7th. Canaccord Genuity Group dropped their price objective on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 7th. Zacks Research downgraded shares of Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, December 22nd. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, two have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, Aspen Aerogels has a consensus rating of “Hold” and a consensus price target of $12.67.

Aspen Aerogels Trading Up 0.8%

The company’s fifty day moving average is $4.34 and its two-hundred day moving average is $6.10. The company has a quick ratio of 3.33, a current ratio of 3.94 and a debt-to-equity ratio of 0.28. The stock has a market cap of $244.97 million, a price-to-earnings ratio of -0.80 and a beta of 2.95.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, November 6th. The construction company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The firm had revenue of $73.02 million during the quarter, compared to analysts’ expectations of $73.42 million. During the same period in the prior year, the company posted ($0.17) earnings per share. The company’s revenue for the quarter was down 37.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, research analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Insiders Place Their Bets

In other Aspen Aerogels news, CEO Donald R. Young sold 56,845 shares of Aspen Aerogels stock in a transaction dated Thursday, November 13th. The stock was sold at an average price of $3.23, for a total transaction of $183,609.35. Following the completion of the sale, the chief executive officer directly owned 494,011 shares of the company’s stock, valued at $1,595,655.53. The trade was a 10.32% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 3.40% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Aspen Aerogels

Several hedge funds and other institutional investors have recently made changes to their positions in ASPN. Gagnon Securities LLC acquired a new stake in shares of Aspen Aerogels during the second quarter worth about $11,243,000. Y Intercept Hong Kong Ltd acquired a new position in Aspen Aerogels during the second quarter worth approximately $484,000. Nuveen LLC purchased a new stake in Aspen Aerogels in the first quarter valued at approximately $1,083,000. Palogic Value Management L.P. boosted its holdings in shares of Aspen Aerogels by 43.5% in the second quarter. Palogic Value Management L.P. now owns 610,000 shares of the construction company’s stock valued at $3,611,000 after acquiring an additional 185,000 shares during the period. Finally, SG Americas Securities LLC boosted its holdings in shares of Aspen Aerogels by 98.6% in the second quarter. SG Americas Securities LLC now owns 133,821 shares of the construction company’s stock valued at $792,000 after acquiring an additional 66,427 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.